Among the cancer-related factors, disease duration (OR, 0.85; 95% CI, 0.76-0.96) and GnRH treatment (OR, 1.68; 95% CI, 1.15-2.44) were associated with depression. Here, GNRH1 is linked to depressive symptom measurement.